Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study

OBJECTIVES: Conventional polyethoxylated castor oil (PCO)-based paclitaxel is associated with major adverse drug reactions (ADRs). Nanoxel, a nanoparticle-based formulation, may improve its tolerability by removing the need for PCO vehicle, and also permit its use in a higher dose. We conducted inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahmachari, Ballari, Hazra, Avijit, Majumdar, Anup
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081448/
https://www.ncbi.nlm.nih.gov/pubmed/21572644
http://dx.doi.org/10.4103/0253-7613.77341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081448/
https://www.ncbi.nlm.nih.gov/pubmed/21572644
http://dx.doi.org/10.4103/0253-7613.77341

Ejemplares similares